Correction: RvE1 attenuates polymicrobial sepsis-induced cardiac dysfunction and enhances bacterial clearance

Frontiers in Immunology, vol. 16, pp. 1659224

Abstract

• please read through all the templates before choosing • pick the most relevant text template(s) from the following page and delete all others.• edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated. In the published article, there was an error in Figure 3A as published. The previous image in Figure 3A (MHCII vs. SSC-A scatter plot) was selected from a mouse in the 24-hour post-CLP group that had received RvE1 treatment, as we initially understood that RvE1-treated mice were also subjected to 24-hour CLP. However, to avoid any further confusion, we have now replaced this scatter plot with an image from a mouse subjected to CLP without RvE1 treatment. This change more accurately reflects the legend of Figure 3A: "(A) Flow cytometry gating strategy of mouse peritoneal immune cells 24 h post-CLP.". The corrected Figure 3

Authors 11

1. Jianmin Chen corresponding

   Queen Mary University of London · William Harvey Research Institute

   Affiliation as printed

   Barts and the London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom

2. Gareth S. D. Purvis

   University of Oxford

   Affiliation as printed

   Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom

3. Debora Collotta

   University of Turin

   Affiliation as printed

   Department of Drug Science and Technology, University of Turin, Turin, Italy

4. Sura AI Zoubi

   Queen Mary University of London · Al-Balqa Applied University · William Harvey Research Institute

   Affiliation as printed

   Barts and the London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom

   Department of Basic Medical Sciences, School of Medicine, Al-Balqa Applied University, As-Salt, Jordan

5. Michelle A. Sugimoto

   Queen Mary University of London · William Harvey Research Institute

   Affiliation as printed

   Barts and the London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom

6. Antonino Cacace

   University College Dublin · Queen Mary University of London · William Harvey Research Institute

   Affiliation as printed

   Barts and the London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom

   Diabetes Complication Research Centre, School of Medicine, UCD Conway Institute, University College Dublin, Dublin, Ireland

7. Lukas Märtin Aachen Department of Intensive Care and Intermediate Care

   Queen Mary University of London · Universitätsklinikum Aachen · William Harvey Research Institute · RWTH Aachen University

   Affiliation as printed

   Barts and the London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom

   Department of Intensive Care and Intermediate Care, RWTH University Hospital Aachen, Aachen, Germany

8. Roman A. Colas

   Queen Mary University of London · William Harvey Research Institute

   Affiliation as printed

   Barts and the London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom

9. Massimo Collino

   University of Turin

   Affiliation as printed

   Department of Drug Science and Technology, University of Turin, Turin, Italy

10. Jesmond Dalli

    Queen Mary University of London · William Harvey Research Institute

    Affiliation as printed

    Barts and the London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom

11. Christoph Thiemermann corresponding

    Queen Mary University of London · William Harvey Research Institute

    Affiliation as printed

    Barts and the London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom